Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes

Free Radical Biology and Medicine

Volumn 86, Issue , 2015, Pages 16-24

  Patente, Thiago A ^a,b   Mohammedi, Kamel ^a,c   Bellili Muñoz, Naïma ^a   Driss, Fathi ^c,d   Sanchez, Manuel ^a   Fumeron, Frédéric ^a,e   Roussel, Ronan ^a,c,e   Hadjadj, Samy ^f,g,h   Corrêa Giannella, Maria Lúcia ^b   Marre, Michel ^a,b,e   Velho, Gilberto ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c BICHAT HOSPITAL   (France)

^d CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f POITIERS UNIVERSITY HOSPITAL   (France)

^g INSERM   (France)

^h UNIVERSITÉ DE POITIERS   (France)

Author keywords

Abbreviations ACE angiotensin converting enzyme; ANCOVA analysis of covariance; ANOVA analysis of variance; AOPP advanced oxidation protein products; CI confidence intervals; eGFR estimated glomerular filtration rate; ESRD end stage renal disease; GENEDIAB G n tique de la N phropathie Diab tique study; HR hazard ratio; MAF minor allele frequency; MDRD Modification of Diet in Renal Disease formula; MPO myeloperoxidase; NADPH nicotinamide adenine dinucleotide phosphate; OR odds ratio; ROS reactive oxygen species; SNP single nucleotide polymorphism; SURGENE Survival Genetic Nephropathy study; UAE urinary albumin excretion; UTR untranslated region

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; CYBA PROTEIN, HUMAN;

ADULT; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CYBA GENE; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; DISEASE SEVERITY; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GENE; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; OXIDATIVE STRESS; PROMOTER REGION; YOUNG ADULT;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NADPH OXIDASE; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84930621494     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.04.002     Document Type: Article

References (57)

1. C.A. Jones, A.S. Krolewski, J. Rogus, J.L. Xue, A. Collins, and J.H. Warram Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? Kidney Int. 67 2005 1684 1691
2. A.T. Reutens Epidemiology of diabetic kidney disease Med. Clin. North Am. 97 2013 1 18
3. J. Pirart, J.P. Lauvaux, and W. Rey Blood sugar and diabetic complications N. Engl. J. Med. 298 1978 1149
4. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med 329 1993 977 986
5. K. Mohammedi, S. Maimaitiming, N. Emery, N. Bellili-Munoz, R. Roussel, F. Fumeron, S. Hadjadj, M. Marre, and G. Velho Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects Mol. Genet. Metab. 104 2011 654 660
6. N. Sandholm, R.M. Salem, A.J. McKnight, E.P. Brennan, C. Forsblom, T. Isakova, G.J. McKay, W.W. Williams, D.M. Sadlier, V.P. Makinen, E.J. Swan, C. Palmer, A.P. Boright, E. Ahlqvist, H.A. Deshmukh, B.J. Keller, H. Huang, A.J. Ahola, E. Fagerholm, D. Gordin, V. Harjutsalo, B. He, O. Heikkila, K. Hietala, J. Kyto, P. Lahermo, M. Lehto, R. Lithovius, A.M. Osterholm, M. Parkkonen, J. Pitkaniemi, M. Rosengard-Barlund, M. Saraheimo, C. Sarti, J. Soderlund, A. Soro-Paavonen, A. Syreeni, L.M. Thorn, H. Tikkanen, N. Tolonen, K. Tryggvason, J. Tuomilehto, J. Waden, G.V. Gill, S. Prior, C. Guiducci, D.B. Mirel, A. Taylor, S.M. Hosseini, H.H. Parving, P. Rossing, L. Tarnow, C. Ladenvall, F. Alhenc-Gelas, P. Lefebvre, V. Rigalleau, R. Roussel, D.A. Tregouet, A. Maestroni, S. Maestroni, H. Falhammar, T. Gu, A. Mollsten, D. Cimponeriu, M. Ioana, M. Mota, E. Mota, C. Serafinceanu, M. Stavarachi, R.L. Hanson, R.G. Nelson, M. Kretzler, H.M. Colhoun, N.M. Panduru, H.F. Gu, K. Brismar, G. Zerbini, S. Hadjadj, M. Marre, L. Groop, M. Lajer, S.B. Bull, D. Waggott, A.D. Paterson, D.A. Savage, S.C. Bain, F. Martin, J.N. Hirschhorn, C. Godson, J.C. Florez, P.H. Groop, and A.P. Maxwell New susceptibility loci associated with kidney disease in type 1 diabetes PLoS Genet. 8 2012 e1002921
7. K. Mohammedi, T.A. Patente, N. Bellili-Munoz, F. Driss, M.B. Monteiro, R. Roussel, E.J. Pavin, N. Seta, F. Fumeron, M.J. Azevedo, L.H. Canani, S. Hadjadj, M. Marre, M.L. Correa-Giannella, and G. Velho Catalase activity, allelic variations in the catalase gene and risk of kidney complications in patients with type 1 diabetes Diabetologia 56 2013 2733 2742
8. K. Mohammedi, N. Bellili-Munoz, F. Driss, R. Roussel, N. Seta, F. Fumeron, S. Hadjadj, M. Marre, and G. Velho Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes PLoS One 9 2014 e96916
9. W. Droge Free radicals in the physiological control of cell function Physiol. Rev. 82 2002 47 95
10. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625
11. M.T. Coughlan, A.L. Mibus, and J.M. Forbes Oxidative stress and advanced glycation in diabetic nephropathy Ann. N. Y. Acad. Sci. 1126 2008 190 193
12. J.M. Forbes, M.T. Coughlan, and M.E. Cooper Oxidative stress as a major culprit in kidney disease in diabetes Diabetes 57 2008 1446 1454
13. Y. Gorin, and K. Block Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? Free Radic. Biol. Med. 61C 2013 130 142
14. V. Witko-Sarsat, M. Friedlander, C. Capeillere-Blandin, T. Nguyen-Khoa, A.T. Nguyen, J. Zingraff, P. Jungers, and B. Descamps-Latscha Advanced oxidation protein products as a novel marker of oxidative stress in uremia Kidney Int. 49 1996 1304 1313
15. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol. Rev. 87 2007 245 313
16. B.M. Babior NADPH oxidase: an update Blood 93 1999 1464 1476
17. G. San Jose, A. Fortuno, O. Beloqui, J. Diez, and G. Zalba NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases Clin. Sci. (Lond.) 114 2008 173 182
18. Y. Gorin, and K. Block Nox as a target for diabetic complications Clin. Sci. (Lond.) 125 2013 361 382
19. M.B. Hampton, A.J. Kettle, and C.C. Winterbourn Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing Blood 92 1998 3007 3017
20. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189
21. A. Daugherty, J.L. Dunn, D.L. Rateri, and J.W. Heinecke Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions J. Clin. Invest. 94 1994 437 444
22. E. Malle, T. Buch, and H.J. Grone Myeloperoxidase in kidney disease Kidney Int. 64 2003 1956 1967
23. P.S. Gill, and C.S. Wilcox NADPH oxidases in the kidney Antioxid. Redox Signal. 8 2006 1597 1607
24. T. Etoh, T. Inoguchi, M. Kakimoto, N. Sonoda, K. Kobayashi, J. Kuroda, H. Sumimoto, and H. Nawata Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment Diabetologia 46 2003 1428 1437
25. K. Asaba, A. Tojo, M.L. Onozato, A. Goto, M.T. Quinn, T. Fujita, and C.S. Wilcox Effects of NADPH oxidase inhibitor in diabetic nephropathy Kidney Int. 67 2005 1890 1898
26. Y. Gorin, K. Block, J. Hernandez, B. Bhandari, B. Wagner, J.L. Barnes, and H.E. Abboud Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney J. Biol. Chem. 280 2005 39616 39626
27. M. Satoh, S. Fujimoto, Y. Haruna, S. Arakawa, H. Horike, N. Komai, T. Sasaki, K. Tsujioka, H. Makino, and N. Kashihara NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy Am. J. Physiol. Renal Physiol 288 2005 F1144 F1152
28. M.B. Monteiro, T.A. Patente, K. Mohammedi, M.S. Queiroz, M.J. Azevedo, L.H. Canani, M.C. Parisi, M. Marre, G. Velho, and M.L. Correa-Giannella Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes Free Radic. Res. 47 2013 804 810
29. M.U. Moreno, G. San Jose, A. Fortuno, O. Beloqui, J. Diez, and G. Zalba The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension J. Hypertens. 24 2006 1299 1306
30. K.I. Kim, J.E. Na, S.Y. Kang, Y.S. Cho, D.J. Choi, C.H. Kim, H.S. Kim, B.H. Oh, Y.H. Choi, I.S. Kwon, and S.C. Park Impact of NAD(P)H oxidase p22 phox gene polymorphism on vascular aging in Korean centenarian and nonagenarian Int. J. Cardiol. 123 2007 18 22
31. A.D. Hodgkinson, B.A. Millward, and A.G. Demaine Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes Diabetes Care 26 2003 3111 3115
32. S.M. Vieira, M.B. Monteiro, T. Marques, A.M. Luna, M.A. Fortes, M. Nery, M. Queiroz, S.A. Dib, M.F. Vendramini, M.J. Azevedo, L.H. Canani, M.C. Parisi, E.J. Pavin, D. Giannella-Neto, and M.L. Correa-Giannella Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus BMC Med. Genet. 12 2011 129
33. S. Hadjadj, R. Belloum, B. Bouhanick, Y. Gallois, G. Guilloteau, G. Chatellier, F. Alhenc-Gelas, and M. Marre Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study J. Am. Soc. Nephrol. 12 2001 541 549
34. M. Marre, X. Jeunemaitre, Y. Gallois, M. Rodier, G. Chatellier, C. Sert, L. Dusselier, Z. Kahal, L. Chaillous, S. Halimi, A. Muller, H. Sackmann, B. Bauduceau, F. Bled, P. Passa, and F. Alhenc-Gelas Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group J. Clin. Invest. 99 1997 1585 1595
35. S. Hadjadj, F. Pean, Y. Gallois, P. Passa, R. Aubert, L. Weekers, V. Rigalleau, B. Bauduceau, A. Bekherraz, R. Roussel, B. Dussol, M. Rodier, R. Marechaud, P.J. Lefebvre, and M. Marre Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium study Diabetes Care 27 2004 2661 2668
36. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann. Intern. Med. 130 1999 461 470
37. E.M. Kohner The lesions and natural history of diabetic retinopathy B. Scientific, Text book of diabetes 1991 Oxford 575 588
38. M.U. Moreno, G. San Jose, A. Fortuno, O. Beloqui, J. Redon, F.J. Chaves, D. Corella, J. Diez, and G. Zalba A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension J. Hypertens. 25 2007 1620 1626
39. D.R. Nyholt A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other Am. J. Hum. Genet. 74 2004 765 769
40. M.U. Moreno, G. San Jose, J. Orbe, J.A. Paramo, O. Beloqui, J. Diez, and G. Zalba Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension FEBS Lett. 542 2003 27 31
41. G. San Jose, M.U. Moreno, S. Olivan, O. Beloqui, A. Fortuno, J. Diez, and G. Zalba Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension Hypertension 44 2004 163 169
42. G. Goliasch, F. Wiesbauer, A. Grafl, E. Ponweiser, H. Blessberger, I. Tentzeris, J. Wojta, M. Schillinger, K. Huber, G. Maurer, C. Mannhalter, and R. Sunder-Plassmann The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (
43. M. Fan, O.T. Raitakari, M. Kahonen, M. Juonala, N. Hutri-Kahonen, I. Porsti, J. Viikari, and T. Lehtimaki The association between cigarette smoking and carotid intima-media thickness is influenced by the -930A/G CYBA gene polymorphism: the Cardiovascular Risk in Young Finns study Am. J. Hypertens. 22 2009 281 287
44. A. Vibhuti, E. Arif, A. Mishra, D. Deepak, B. Singh, I. Rahman, G. Mohammad, and M.A. Pasha CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD Clin. Chim. Acta 411 2010 474 480
45. A. Mishra, Z. Ali, A. Vibhuti, R. Kumar, P. Alam, R. Ram, T. Thinlas, G. Mohammad, and M.A. Pasha CYBA and GSTP1 variants associate with oxidative stress under hypobaric hypoxia as observed in high-altitude pulmonary oedema Clin. Sci. (Lond.) 122 2012 299 309
46. T.J. Guzik, N.E. West, E. Black, D. McDonald, C. Ratnatunga, R. Pillai, and K.M. Channon Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis Circulation 102 2000 1744 1747
47. Y. Shimo-Nakanishi, T. Hasebe, A. Suzuki, H. Mochizuki, T. Nomiyama, Y. Tanaka, I. Nagaoka, Y. Mizuno, and T. Urabe Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction Atherosclerosis 175 2004 109 115
48. S. Nasti, P. Spallarossa, P. Altieri, S. Garibaldi, P. Fabbi, L. Polito, L. Bacino, M. Brunelli, C. Brunelli, A. Barsotti, and G. Ghigliotti C242T polymorphism in CYBA gene (p22phox) and risk of coronary artery disease in a population of Caucasian Italians Dis. Markers 22 2006 167 173
49. S. Fang, L. Wang, and C. Jia Association of p22phox gene C242T polymorphism with coronary artery disease: a meta-analysis Thromb. Res. 125 2010 e197 201
50. K.G. Santos, L.H. Canani, J.L. Gross, B. Tschiedel, K.E. Souto, and I. Roisenberg Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients J. Nephrol 18 2005 733 738
51. M.C. Perianayagam, O. Liangos, A.Y. Kolyada, R. Wald, R.W. MacKinnon, L. Li, M. Rao, V.S. Balakrishnan, J.V. Bonventre, B.J. Pereira, and B.L. Jaber NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure J. Am. Soc. Nephrol. 18 2007 255 263
52. 2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells J. Biol. Chem. 278 2003 33951 33962
53. R. Yong, X.M. Chen, S. Shen, S. Vijayaraj, Q. Ma, C.A. Pollock, and S. Saad Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling PLoS One 8 2013 e73428
54. M. Sedeek, A. Gutsol, A.C. Montezano, D. Burger, A. Nguyen Dinh Cat, C.R. Kennedy, K.D. Burns, M.E. Cooper, K. Jandeleit-Dahm, P. Page, C. Szyndralewiez, F. Heitz, R.L. Hebert, and R.M. Touyz Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes Clin. Sci. (Lond.) 124 2013 191 202
55. V. Thallas-Bonke, J.C. Jha, S.P. Gray, D. Barit, H. Haller, H.H.H.W. Schmidt, M.T. Coughlan, M.E. Cooper, J.M. Forbes, and K.A.M. Jandeleit-Dahm Nox-4 deletion reduces oxidative stress and injury by PKC-a-associated mechanisms in diabetic nephropathy Physiol. Rep. 2 2014 e12192
56. X.Y. Shi, F.F. Hou, H.X. Niu, G.B. Wang, D. Xie, Z.J. Guo, Z.M. Zhou, F. Yang, J.W. Tian, and X. Zhang Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase Endocrinology 149 2008 1829 1839
57. X.F. Wei, Q.G. Zhou, F.F. Hou, B.Y. Liu, and M. Liang Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase Am. J. Physiol. Renal Physiol 296 2009 F427 F437